A Shortcut to Immortality: Rapid Reprogramming with Tissue Cells
Liza Gross | doi:10.1371/journal.pbio.0060275 In 1981, researchers working independently on two continents ushered in a new era of biomedicine by isolating stem cells from early mouse embryos and sustaining the famously finicky cells in Petri dishes. These cultured "pluripotent" cells, which can generate any of the 200-plus cell types in the body, looked and behaved like normal embryo cells, giving researchers a powerful model for understanding development and disease. But efforts to develop similar tools working with human embryonic stem (ES) cells stalled when ethical and legal restrictions on human embryos and embryonic cell lines hamstrung a field still in its infancy.
The Immunofluorescence staining for two indicators of pluripotency, trimethyl H3K27 and Nanog, in cells that had undergone induced pluripotent stem cell reprogramming.
wondered whether these conditions could jumpstart the resetting process in the partially reprogrammed cells. They used a culture medium spiked with two small molecule inhibitors (2i) and bathed the cells with a factor (LIF) known to maximize ES cell selfrenewal. Treated MEF cells yielded far fewer undifferentiated colonies than the NS cells, which passed all the tests of pluripotency: appropriate levels of ES cell marker expression; silencing of retroviral transgenes; gene expression from both X chromosomes; and the gold standard, healthy chimeric mice. Injecting 2i-iPS cells into mouse blastocysts generated live mice, indicating that the iPS cells had acted like normal ES cells to produce all the cell types that form a mouse, including the germ cells.
Silva et al. go on to show that their 2i cocktail induced transition to pluripotency, rather than selecting rare cells that had already reached that state by chance. Furthermore, NS cells could reach pluripotency with just two of the reprogramming factors, Oct4 and Klf4, though with less efficiency.
This reprogramming approach produces cells in an undifferentiated but not pluripotent "pre-iPS" state-"poised on the threshold of pluripotency"-that can be stably maintained and propagated, then rapidly converted to pluripotency with a 2i/LIF elixir. This recipe may provide a final push by imposing what the researchers call a "ground state," in which cells exist free of differentiation and epigenetic restrictions while retaining the ability to self-renew indefinitely. Because this technique requires fewer viral integrations, it may reduce the risk of cancer-promoting transgene integrations, a concern for using human iPS cells in regenerative medicine. And because it can yield abundant colonies of iPS cells with relative speed, it offers embattled stem cell researchers a flexible new technique for understanding one of biology's most enduring mysteries: how pluripotent cells maintain the delicate balance between differentiation and immortality.
